QoL Cancer Research Results

QoL, Quality of Life: Click to Expand ⟱
Source:
Type:
Quality of Life


Scientific Papers found: Click to Expand⟱
8604- FSO,  VitD3,    An 8-Week Triple-Blind, Randomized, Placebo-Controlled Trial Evaluating High-Dose Vitamin D3 and Flaxseed Oil for Inflammation and Metabolic Health in Elderly Patients With Type 2 Diabetes: Implications for Clinical Management
- Trial, Diabetic, NA
*TAC↑, *Weight↓, *glucose↓, *Insulin↓, *TG/TAG↓, *TC↓, *QoL↑, *Pain↓, *toxicity↓, *Dose↝,
7023- Fuc,    The Use of Oligo Fucoidan in Cancer Bearing Dogs Undergoing Chemotherapy: A Double-Blinded Study
- Trial, Var, NA
QoL∅, QoL↑,
7000- Fuc,    Efficacy of Low-Molecular-Weight Fucoidan as a Supplemental Therapy in Metastatic Colorectal Cancer Patients: A Double-Blind Randomized Controlled Trial
- Trial, CRC, NA
DCR↑, OS∅, PFS∅, ORR∅, AEs∅, QoL∅,
7007- Fuc,    The Therapeutic Potential of the Anticancer Activity of Fucoidan: Current Advances and Hurdles
- Review, Var, NA
TumCCA↑, Apoptosis↑, NK cell↑, chemoP↑, TumCG↓, *Inflam↓, *antiOx↑, *AntiThr↑, *AntiViral↑, angioG↓, ChemoSen↑, ROS↑, GSH↓, mtDam↓, MMP↓, DNMT3B↓, TumCG↓, Dose↝, Dose↝, QoL∅, fatigue∅, Dose↝,
7143- GI,  Chemo,    Effect of a Standardized Ginger Root Powder Regimen on Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Double-Blind, Placebo-Controlled Randomized Trial
- Trial, Var, NA
Dose↝, chemoPv↑, Nausea↓, Vomit↓, mal↓, QoL↑,
7482- H2,    Molecular Hydrogen Therapy: Mechanisms, Delivery Methods, Preventive, and Therapeutic Application
- Review, Var, NA - Review, IBD, NA - Review, Stroke, NA - Review, Sepsis, NA - Review, AD, NA
Dose↝, *Inflam↓, *IL1β↓, *IL6↓, *TNF-α↓, *neuroP↑, *mTOR↓, *IL10↑, *TGF-β↑, *Sepsis↓, *NRF2↑, *antiOx↑, *Catalase↑, *SOD↑, *GPx↑, *ROS↓, *HO-1↑, *PI3K↑, *Akt↑, *hepatoP↑, *MPO↓, *cardioP↑, CDK4↓, CDK6↑, CD47↓, PI3K↓, Akt↓, Hif1a↓, selectivity↑, *MMP↑, *ATP↑, *ER Stress↓, *CHOP/DDIT3↓, *Casp12↓, *GRP78/BiP↓, *p38↓, *p‑JNK↓, *LC3‑Ⅱ/LC3‑Ⅰ↑, *p‑eIF2α↓, *ATF4↓, *XBP-1↓, *Imm↑, *IFN-γ↓, *IL4↓, *GranB/GZMB↓, NK cell↑, radioP↑, *CD4+↑, CD8+↑, *Dose↝, *other↑, *Dose↝, *antiPs↑, *BioAv↝, *GutMicro↑, Dose↝, *IBI↑, TumCP↓, TumCI↓, TumCMig↓, CD8+↑, PGC-1α↑, Akt↓, SCD1↓, *MDA↓, Synergy↑, *APP↓, *BACE/β-secretase↓, *Aβ↓, *cognitive↑, *neuroP↑, NP/CIPN↓, *Stroke↓, *NLRP3↓, *ALAT↓, *AST↓, *LPS↓, *hepatoP↑, chemoP↑, *creat↓, *Urea↓, *RenoP↑, *eff↑, Apoptosis↑, XIAP↓, IAP2/BIRC3↓, TumVol↓, MALAT1↓, EZH2↓, miR-124-3p↓, eff↑, ChemoSen↑, *compII↑, *compIII↑, *LDL↓, *Obesity↓, QoL↑, PFS↑, *antiAll↑,
7489- H2,    Molecular Hydrogen in the Treatment of Respiratory Diseases
- Review, Asthma, NA
*antiOx↑, *Inflam↓, *Apoptosis↓, *Dose↓, *Dose↝, *eff↑, *ROS↓, *RNS↓, *NRF2↑, *HO-1↑, *Fenton↓, *NLRP3↓, *NADPH↓, *NOX4↓, *NOX↓, *MPO↓, *NF-kB↓, *TNF-α↓, *IL6↓, *IL1β↓, *HMGB1↓, *IL4↑, *IL10↑, *M2 MC↑, *Treg lymp↝, *Bcl-2↑, *Bcl-xL↑, *PI3K↑, *Akt↑, *JAK2↑, *STAT3↑, *Dose↑, *CD4+↑, *CD25+↑, *FOXP3↑, *MDA↓, *SOD↑, *Catalase↑, *Casp3↓, *Casp9↓, *TBARS↓, *SpO2↑, *VitE↓, *OS↑, *Weight↑, *DNAdam↓, *PGE2↓, *MCP1/CCL2↓, *lipid-P↓, *TumCP↓, *tumCV↓, *TumCMig↓, *TumCI↓, TumW↓, TumVol↓, selectivity↑, QoL↑, ChemoSen↑, chemoP↑, radioP↑, ROS↑, NLRP3↑, Casp3↑, VEGF↓, Wnt↓, β-catenin/ZEB1↓, *antiAll↑,
7490- H2,    Long-term administration of hydrogen-rich water enhances quality of life in diabetic rats and reduces renal neoplasm incidence through modulation of inflammatory and metabolic pathways
- in-vivo, Diabetic, NA
*BG↓, *AntiDiabetic↑, *BMD↑, *hepatoP↑, *RenoP↑, *QoL↑,
2522- H2,    A Systematic Review of Molecular Hydrogen Therapy in Cancer Management
- Review, Var, NA
chemoP↑, OS↑, QoL↑, TumVol↑, ROS↑, AntiTum↑, other↝,
2521- H2,    Oxyhydrogen Gas: A Promising Therapeutic Approach for Lung, Breast and Colorectal Cancer
- Review, CRC, NA - Review, Lung, NA - Review, BC, NA
Inflam↑, ROS↓, ChemoSen↑, p‑PI3K↓, p‑Akt↓, QoL↑, GutMicro↑, chemoP↑, radioP↑, *NRF2↑, *Catalase↑, *GPx↑, *HO-1↑, *SOD↑, *TNF-α↓, *IL4↓, *IL6↓, ChemoSen↑, Appetite↑, cognitive↑, Pain↓, Sleep↑, other?,
3152- H2,  VitC,  Rad,    Hydrogen and Vitamin C Combination Therapy: A Novel Method of Radioprotection
- in-vitro, Nor, HUVECs - in-vivo, NA, NA
AntiTum↑, OS↑, QoL↑, TumVol↓, radioP↑, Dose↑, Dose↝, Synergy↑,
7373- HOO,    Effects of topical ozonated olive oil on lipid profile, quality of life, wound healing and glycemic control in patients with diabetic foot ulcers: a randomized controlled trial
- Trial, Diabetic, NA
*Wound Healing↑, *QoL↑,
7622- HPT,    A Review of the Current Clinical Evidence for Loco-Regional Moderate Hyperthermia in the Adjunct Management of Cancers
- Review, Var, NA
LC↑, OS↑, QoL↑, toxicity↓, Dose↝, Dose↝, ROS↑, DNArepair↓, EPR↑, DNAdam↑, HSP70/HSPA5↑, BloodF↑, Hypoxia↓,
7643- Ins,  IP6,    Efficacy of IP6 + inositol in the treatment of breast cancer patients receiving chemotherapy: prospective, randomized, pilot clinical stud
- Trial, BC, NA
RBC↑, QoL↑, Synergy↑, Imm↑, ChemoSen↑, chemoP↑, Dose↝,
7631- Ins,  IP6,    Broad Spectrum Anticancer Activity of Myo-Inositol and Inositol Hexakisphosphate
- Review, Var, NA
other↑, p‑pRB↓, TumCCA↑, PI3K↓, Akt↓, ERK↓, NF-kB↓, COX2/PTGS2↓, PGE2↓, PSEN1/PS1↓, EMT↓, Wnt↓, β-catenin/ZEB1↓, NOTCH1↓, N-cadherin↓, Snail↓, E-cadherin↑, fascin↓, Cofilin↓, MMPs↓, ROCK1↓, Dose↝, other↝, selectivity↑, *ROS↓, *lipid-P↓, ROS↑, NK cell↑, Imm↑, TNF-α↓, ChemoSen↑, Dose↑, toxicity↓, QoL↑, chemoP↑, OS↑, Dose↝, Insulin↓, glucose↝, lipoGen↓, Synergy↑,
7722- IP6,    Cancer inhibition by inositol hexaphosphate (IP6) and inositol: from laboratory to clinic
- Review, Var, NA
Synergy↑, TumCP↓, Diff↑, TumCCA↑, Imm↑, antiOx↑, BioAv↑, toxicity↓, ChemoSen↑, TumMeta↓, QoL↑,
7640- IP6,  Ins,    Effects of Inositol Hexaphosphate and Myo-Inositol Administration in Breast Cancer Patients during Adjuvant Chemotherapy
- Trial, BC, NA
*antiOx↑, QoL↑, RBC↑, HemoG↑, WBC↑, chemoP↑, Dose↝,
7646- IP6,  Ins,    Protection against cancer by dietary IP6 and inositol
- Review, Var, NA
*antiOx↑, TumCG↓, TumMeta↓, Imm↑, kidSt↓, LDL↓, TumCCA↑, TumCP↓, Diff↑, ChemoSen↑, QoL↑,
7699- IP6,    IP6: From Seeds to Science—A Natural Compound’s Path to Clinical Promise
- Review, Var, NA
*Iron∅, ChemoSen↑, *cardioP↑, neuroP↑, IronCh∅, P21↓, p27/CDKN1B↓, p‑pRB↓, PI3K↓, Akt↓, NF-kB↓, Inflam↓, TumW↓, TumCI↓, TumMeta↓, Imm↑, Diff↑, selectivity↑, toxicity↓, RenoP↑, QoL↑,
7705- IP6,    Inositol hexaphosphate (InsP6) as an effective topical treatment for patients receiving adjuvant chemotherapy after breast surgery
- Human, BC, NA
QoL↑, chemoP↑,
7990- itraC,    A Novel Approach to Reducing Chemoresistance in Advanced Ovarian Cancer: The Effect of Itraconazole-A Single-Institution Randomized Placebo-Controlled Trial
- Trial, Ovarian, NA
Dose↝, DCR↑, PFS↑, CA125↓, P-gp/ABCB1↓, VEGFR2/KDR/Flk1↑, toxicity↓, QoL↑, toxicity↝,
8341- LDN,    Low-Dose Naltrexone as an Adjuvant in Combined Anticancer Therapy
- Review, Var, NA
OGFr↑, TumCP↓, TumCCA↑, Apoptosis↑, toxicity↝, Half-Life↝, *FasL↓, *Fas↓, BAX↑, Casp9↑, Casp3↑, Bcl-2↓, survivin↓, PI3K↓, PDK1 / PDPK1↓, mTOR↓, ChemoSen↑, chemoP↑, Synergy↑, QoL∅,
3980- Lut,  Zeax,    Supplementation With Carotenoids, Omega-3 Fatty Acids, and Vitamin E Has a Positive Effect on the Symptoms and Progression of Alzheimer's Disease
- Trial, AD, NA
*eff↑, *memory↑, *Mood↑, *QoL↑,
3979- Lut,    Increases in Plasma Lutein through Supplementation Are Correlated with Increases in Physical Activity and Reductions in Sedentary Time in Older Adults
- Trial, AD, NA
*other↑, *QoL↑,
1708- Lyco,    The Anti-Cancer Activity of Lycopene: A Systematic Review of Human and Animal Studies
- Review, Var, NA
OS↑, ChemoSen↑, QoL↑, PSA∅, Synergy↑, AntiCan↑, AntiCan↑, angioG↓, VEGF↓, Hif1a↓, SOD↑, Catalase↑, GPx↑, GSH↑, GPx↑, GR↑, MDA↓, NRF2↑, HO-1↑, COX2/PTGS2↓, PGE2↓, NF-kB↓, IL4↑, IL10↑, IL6↓, TNF-α↓, PPARγ↑, TumCCA↑, FOXO3↓, Casp3↑, IGF-1↓, p27/CDKN1B↑, STAT3↓, CDK2↓, CDK4↓, P21↑, PCNA↓, MMP7↓, MMP9↓,
8577- Matr,  Cisplatin,    Meta analysis of compound matrine injection combined with cisplatin chemotherapy for advanced gastric cancer
- Review, GC, NA
ChemoSen↑, QoL↑, chemoP↑,
8648- MBZ,    Mebendazole as a Candidate for Drug Repurposing in Oncology: An Extensive Review of Current Literature
- Review, Var, NA
angioG↓, MMPs↓, MDR1↓, TubPol↓, RadioS?, ChemoSen?, TumCG↓, TumMeta?, OS↑, BioAv↓, BioAv↑, BBB↑, mitA↑, HH↓, Shh↓, Synergy↑, Gli1↓, PTCH2↓, XIAP↓, cl‑PARP↑, Casp3↑, BRAF↓, MEK↓, SYN1↑, Cyt‑c↑, TumVol↓, VEGFR2/KDR/Flk1↓, VEGF↓, VCAM-1↓, DYRK1B↓, QoL↑, Dose↝,
8797- mCHEMO,    Metronomic chemotherapy and drug repurposing: A paradigm shift in oncology
- Review, Var, NA
ChemoSideEff↓, QoL↑,
8787- mCHEMO,    Optimizing cancer therapy: a review of the multifaceted effects of metronomic chemotherapy
- Review, Var, NA
*toxicity↓, angioG↓, Imm↑, DCells↑, T-Cell↑, CSCs?, chemoR↓, QoL↑, RadioS↑, Synergy↑,
8824- MCP,    Clinical Benefit in Patients with Advanced Solid Tumors Treated with Modified Citrus Pectin: A Prospective Pilot Study
- Trial, Var, NA
toxicity↓, Dose↝, CR↑, QoL↑, SD↑, PSA↓,
4111- MF,    Coupling of pulsed electromagnetic fields (PEMF) therapy to molecular grounds of the cell
- Review, Arthritis, NA
*Inflam↓, *Cartilage↑, *Pain↓, *QoL↑, *Dose↝, *VEGF↑, *NO↑, *TGF-β↑, *MMP9↓, *PGE2↑, *GPx3↑, *SOD2↑, *Catalase↑, *GSR↑, *Ca+2↑,
3566- MF,    Positive and Negative Effects of Administering a Magnetic Field to Patients with Rheumatoid Arthritis (RA)
- Study, Arthritis, NA
*Inflam↓, *QoL↑, *Pain↓, *motorD↑, *toxicity↓, *Cartilage↑, *Inflam↓,
3569- MF,    Current Evidence Using Pulsed Electromagnetic Fields in Osteoarthritis: A Systematic Review
- Review, Arthritis, NA
*Pain↓, *QoL↑, *motorD↑,
6940- MF,    Meta-analysis of the effectiveness and safety of magnetic stimulation for chronic pelvic pain
- Review, BPH, NA
*UFR↑, *other?, *Pain↓, *BloodF↑, *other↑, *Inflam↓, *QoL↑,
529- MF,    Low-frequency magnetic field therapy for glioblastoma: Current advances, mechanisms, challenges and future perspectives
- Review, GBM, NA
Ca+2↑, ROS↑, ChemoSen↑, QoL↑, OS↑,
4349- MF,    Long-term effect of full-body pulsed electromagnetic field and exercise protocol in the treatment of men with osteopenia or osteoporosis: A randomized placebo-controlled trial
- Trial, ostP, NA
*BMD↑, *Pain↓, *QoL↑, *toxicity↓, *Dose↝, *Inflam↓,
190- MFrot,  MF,  Chemo,    The efficacy and safety of low-frequency rotating static magnetic field therapy combined with chemotherapy on advanced lung cancer patients: a randomized, double-blinded, controlled clinical trial
- Human, Lung, NA
*IP-10/CXCL-10↑, *GM-CSF↑, *TREM-1↓, QoL↑, Ca+2↑, ROS↑, Apoptosis↑, OS↑,
198- MFrot,  MF,    Biological effects of rotating magnetic field: A review from 1969 to 2021
- Review, Var, NA
AntiCan↑, breath↑, Pain↓, Appetite↑, Strength↑, BowelM↑, TumMeta↓, TumCCA↑, ETC↓, MMP↓, TumCD↑, selectivity↑, ROS↑, Casp3↑, TumCG↓, TumCCA↑, ChrMod↑, TumMeta↓, Imm↑, DCells↑, Akt↓, OS⇅, toxicity↓, QoL↑, hepatoP↑, Pain↓, Weight↑, Strength↑, Sleep↑, IL6↓, CD4+↑, CD8+↑, Ca+2↑, radioP↑, chemoP↑, *BMD↑, *AntiAge↑, *AMPK↑, *P21↓, *P53↓, *mTOR↓, *OS↑, *β-Endo↑, *5HT↓,
1779- MLT,    Therapeutic Potential of Melatonin Counteracting Chemotherapy-Induced Toxicity in Breast Cancer Patients: A Systematic Review
- Review, BC, NA
QoL↑, OS↑, Dose∅, antiOx↑, ROS↑, SOD↑, Catalase↑, GPx↑, Risk↓, NK cell↑, IL1β↓, IL6↓, TNF-α↓, radioP↑, chemoP↑, TumVol↓, TumMeta↓, angioG↓, ChemoSen↑, eff↑,
1781- MLT,    Melatonin in patients with cancer receiving chemotherapy: a randomized, double-blind, placebo-controlled trial
- Trial, Lung, NA
QoL↑, OS∅, selectivity↑,
7493- MLT,    Effect of melatonin supplementation on tinnitus: systematic literature review and meta-analysis Melatonin and Tinnitus
- Review, Nor, NA
*Tinn↓, *QoL↑,
8613- MO,    Unraveling the Effects of Melissa officinalis L. on Cognition and Sleep Quality: A Narrative Review
- Review, AD, NA
*Sleep↑, *Mood↑, *Synergy↑, *QoL↑, *cognitive↑, *ROS↓, *NRF2↑, *HO-1↑, *NF-kB↓, *TNF-α↓, *COX2/PTGS2↓, *MDA↓, *Catalase↑, *SOD↑, *BDNF↑, *Dose↝,
3851- MSM,    Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial
- Trial, Arthritis, NA
*Pain↓, *QoL↑,
8805- MT/VAE,  Chemo,    Mistletoe extract in patients with advanced pancreatic cancer: Health-related quality of life in a double-blind, randomized, placebo-controlled trial (MISTRAL)
- Trial, PC, NA
Dose?, QoL∅, Weight∅, CRP∅, ALB∅, Eos↑, eff∅, Synergy∅,
8800- MT/VAE,    Phase I Trial of Intravenous Mistletoe Extract in Advanced Cancer
- Trial, Var, NA
Dose↝, QoL↑, DCR↑, Dose↝, other↝,
7342- MT/VAE,  Hne,    Minor regression and long-time survival (56 months) in a patient with malignant pleural mesothelioma under Viscum album and Helleborus niger extracts—a case report
- Case Report, MM, NA
angioG↓, TumVol↓, QoL↑, OS↑, Dose↝,
1573- MushReishi,    Ganoderma lucidum (Reishi mushroom) for cancer treatment
- Review, Var, NA
ChemoSen↑, CR3↝, eff↑, NK cell↑, T-Cell↑, QoL↑,
4648- OLEC,    The Effect of Dietary Intervention With High-Oleocanthal and Oleacein Olive Oil in Patients With Early-Stage Chronic Lymphocytic Leukemia: A Pilot Randomized Trial
- Trial, CLL, NA
Apoptosis↑, *QoL↑,
7290- PacT,  Aidi,    Clinical efficacy and safety of Aidi injection plus paclitaxel-based chemotherapy for advanced non-small cell lung cancer: A meta-analysis of 31 randomized controlled trials following the PRISMA guidelines
- in-vitro, NSCLC, NA
Dose↝, QoL↑, hepatoP↑, GastroP↑, chemoP↑, Dose↝,
9053- PatchO,    Effects of Short-Term Inhalation of Patchouli Oil on Professional Quality of Life and Stress Levels in Emergency Nurses: A Randomized Controlled Trial
- Trial, Nor, NA
*Dose?, *Stress↓, *QoL↑,

Showing Research Papers: 51 to 100 of 113
Prev Page 2 of 3 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 113

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↑, 2,   Catalase↑, 2,   GPx↑, 3,   GPx4↓, 2,   GSH↓, 2,   GSH↑, 1,   HO-1↑, 1,   c-Iron↑, 1,   lipid-P↑, 1,   MDA↓, 1,   NRF2↓, 1,   NRF2↑, 2,   ROS↓, 1,   ROS↑, 18,   SOD↑, 2,   xCT/SLC7A11↓, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh∅, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

ETC↓, 1,   Insulin↓, 4,   mtDam↓, 1,   OXPHOS↑, 1,   mt-OXPHOS↓, 1,   PGC-1α↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

ACSL4↑, 1,   AMPK↑, 2,   ATP↓, 1,   glucose↓, 1,   glucose↝, 1,   Glycolysis↓, 2,   GSK‐3β↓, 1,   GSK‐3β↑, 1,   LDL↓, 1,   LDL↑, 1,   lipoGen↓, 1,   PDK1 / PDPK1↓, 1,   SCD1↓, 1,   SIRT1↓, 1,   SREBP1/SREBF1↓, 1,   Warburg↓, 1,  

Cell Death(tgid=5) ⓘ

Apoptosis↑, 11,   BAX↑, 3,   Bcl-2↓, 3,   Casp↑, 1,   Casp3↑, 8,   Casp8↑, 1,   Casp9↑, 4,   Cyt‑c↑, 2,   Cyt‑c↝, 1,   Fas↑, 1,   Ferroptosis↑, 1,   IAP2/BIRC3↓, 1,   Perforin↑, 1,   survivin↓, 1,   TumCD↑, 2,   XIAP↓, 2,   XIAP↑, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 8,   p‑Akt↓, 1,   BRAF↓, 1,   DYRK1B↓, 1,   EGFR↓, 4,   ERK↓, 2,   JAK1↓, 1,   JNK↓, 1,   MAPK↓, 1,   MEK↓, 1,   mTOR↓, 5,   PI3K↓, 7,   p‑PI3K↓, 1,   RAS↓, 1,   STAT↓, 1,   STAT3↓, 3,  

Transcription & Epigenetics(tgid=7) ⓘ

ChrMod↑, 1,   DNMT3B↓, 1,   EZH2↓, 1,   FOXO1↑, 1,   FOXO3↓, 1,   miR-124-3p↓, 1,   miR-133a-3p↑, 1,   other?, 1,   other↓, 1,   other↑, 2,   other↝, 6,   SD↑, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

ER Stress↑, 1,   HSP70/HSPA5↑, 1,   HSPs↑, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

Beclin-1/ATG6↑, 1,   TumAuto↓, 1,   TumAuto↑, 2,   mt-TumAuto↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

BRCA1↑, 1,   BRCA2↑, 1,   DNAdam↑, 3,   DNArepair↓, 1,   P53↑, 4,   cl‑PARP↑, 2,   PCNA↓, 1,   γH2AX↑, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK2↓, 1,   CDK4↓, 2,   CDK6↑, 1,   cycD1/CCND1↓, 1,   mitA↑, 1,   P21↓, 1,   P21↑, 3,   p27/CDKN1B↓, 1,   p27/CDKN1B↑, 1,   p‑pRB↓, 2,   TubPol↓, 1,   TumCCA↑, 13,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

CD133↓, 1,   CSCs?, 1,   CSCs↓, 2,   Diff↑, 3,   Gli1↓, 1,   HH↓, 1,   IGF-1↓, 6,   IGF-1↑, 1,   IGFBP3↑, 1,   mTORC1↓, 1,   NOTCH1↓, 3,   NOTCH3↓, 1,   OGFr↑, 1,   PTCH2↓, 1,   Shh↓, 1,   TumCG↓, 11,   TumCP↓, 11,   Wnt↓, 5,  

Migration(tgid=13) ⓘ

Ca+2↑, 3,   Cofilin↓, 1,   E-cadherin↑, 1,   EMT↓, 3,   fascin↓, 1,   KRAS↓, 1,   MALAT1↓, 1,   MMP7↓, 1,   MMP9↓, 2,   MMPs↓, 2,   N-cadherin↓, 1,   ROCK1↓, 1,   Snail↓, 1,   TumCI↓, 4,   TumCMig↓, 2,   TumMeta?, 1,   TumMeta↓, 8,   Vim↓, 2,   β-catenin/ZEB1↓, 5,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 9,   Hif1a↓, 3,   Hif1a↝, 1,   Hypoxia↓, 1,   VCAM-1↓, 1,   VEGF↓, 4,   VEGFR2/KDR/Flk1↓, 1,   VEGFR2/KDR/Flk1↑, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 2,   EPR↑, 1,   GastroP↑, 1,   GLUT1↓, 1,   GLUT2↓, 1,   MMP↓, 6,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

ANXA1↓, 1,   CD4+↑, 1,   CD44↓, 1,   CD47↓, 1,   CD8+↑, 3,   COX2/PTGS2↓, 5,   CR3↝, 1,   CXCR4↓, 1,   DCells↑, 2,   Eos↑, 1,   IL10↑, 1,   IL12↑, 1,   IL1β↓, 1,   IL2↑, 1,   IL4↑, 1,   IL6↓, 5,   Imm↑, 12,   Inflam↓, 3,   Inflam↑, 1,   M2 MC↓, 1,   NF-kB↓, 6,   NK cell↑, 6,   NLRP3↑, 1,   PD-L1↓, 1,   PGE1↓, 1,   PGE2↓, 2,   PSA↓, 2,   PSA∅, 1,   Resistin↓, 1,   T-Cell↑, 2,   TNF-α↓, 4,   TNF-α↑, 1,  

Cellular Microenvironment(tgid=17) ⓘ

pH↝, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

SYN1↑, 1,  

Protein Aggregation(tgid=19) ⓘ

PSEN1/PS1↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AR↓, 1,   GR↑, 1,   Irisin↓, 1,   Leptin↓, 1,   PPARγ↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 2,   BioAv↑, 3,   BioAv↝, 1,   chemoR↓, 1,   ChemoSen?, 1,   ChemoSen↑, 33,   Dose?, 2,   Dose↑, 5,   Dose⇅, 1,   Dose↝, 40,   Dose∅, 5,   eff↑, 16,   eff↝, 2,   eff∅, 2,   Half-Life↑, 2,   Half-Life↝, 1,   MDR1↓, 2,   P-gp/ABCB1↓, 3,   RadioS?, 1,   RadioS↑, 5,   selectivity↑, 9,   Synergy↑, 10,   Synergy∅, 1,   TET2↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

ALB∅, 1,   AR↓, 1,   BG↓, 2,   BloodF↑, 1,   BMD↑, 1,   BRAF↓, 1,   BRCA1↑, 1,   CA125↓, 1,   CEA↓, 1,   CRP↓, 1,   CRP∅, 1,   EGFR↓, 4,   EZH2↓, 1,   HemoG↑, 1,   IL6↓, 5,   KRAS↓, 1,   PD-L1↓, 1,   PSA↓, 2,   PSA∅, 1,   RBC↑, 2,   WBC↑, 1,  

Functional Outcomes(tgid=23) ⓘ

AEs∅, 1,   AntiCan↑, 5,   antiD↑, 2,   AntiTum↑, 4,   ANXi↓, 1,   Appetite↑, 2,   BowelM↑, 2,   breath↑, 1,   chemoP↑, 23,   chemoPv↑, 2,   ChemoSideEff↓, 4,   cognitive↑, 2,   CR↑, 1,   DCR↑, 3,   fatigue↓, 6,   fatigue∅, 1,   hepatoP↑, 2,   hepatoP∅, 1,   kidSt↓, 1,   LC↑, 1,   mal↓, 1,   Mood↑, 1,   Nausea↓, 2,   neuroP↑, 1,   NP/CIPN↓, 1,   ORR∅, 1,   OS?, 1,   OS↑, 24,   OS⇅, 1,   OS↝, 1,   OS∅, 4,   Pain↓, 6,   PFS↑, 2,   PFS∅, 1,   QoL↑, 74,   QoL↝, 1,   QoL∅, 9,   radioP↑, 8,   Remission↑, 1,   RenoP↑, 1,   RenoP∅, 1,   Risk↓, 6,   Sleep↑, 2,   Strength↑, 3,   toxicity↓, 10,   toxicity↑, 1,   toxicity↝, 6,   toxicity∅, 1,   TumVol↓, 8,   TumVol↑, 1,   TumW↓, 2,   Vomit↓, 1,   Weight↑, 6,   Weight∅, 1,  

Infection & Microbiome(tgid=24) ⓘ

GutMicro↑, 2,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↝, 1,  
Total Targets: 303

Pathway results for Effect on Normal Cells:


NA, unassigned(tgid=0) ⓘ

NA↑, 1,   NA↝, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↑, 10,   Catalase↑, 6,   Fenton↓, 1,   GPx↑, 2,   GPx3↑, 1,   GSH↑, 2,   GSR↑, 1,   HDL↑, 1,   HO-1↑, 4,   hyperG↓, 1,   Iron∅, 1,   lipid-P↓, 3,   MDA↓, 4,   MPO↓, 2,   NOX↓, 1,   NOX4↓, 1,   NQO1↑, 1,   NRF2↑, 5,   RNS↓, 1,   ROS↓, 8,   selenoP↑, 2,   SOD↑, 5,   SOD2↑, 1,   TAC↑, 3,   TBARS↓, 1,   VitE↓, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

compII↑, 1,   compIII↑, 1,   Insulin↓, 1,   OXPHOS↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

ALAT↓, 1,   AMPK↑, 1,   ATP↑, 1,   glucose↓, 2,   LDL↓, 4,   NADPH↓, 1,  

Cell Death(tgid=5) ⓘ

Apoptosis↓, 2,   Bcl-2↑, 1,   Bcl-xL↑, 1,   Casp12↓, 1,   Casp3↓, 1,   Casp9↓, 1,   Fas↓, 1,   FasL↓, 1,   GranB/GZMB↓, 1,   p38↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↑, 2,   JAK2↑, 1,   p‑JNK↓, 1,   mTOR↓, 2,   PI3K↑, 2,   STAT3↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 1,   ATF4↓, 1,   other?, 1,   other↑, 4,   other↝, 4,   other∅, 1,   tumCV↓, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↓, 1,   p‑eIF2α↓, 1,   ER Stress↓, 1,   GRP78/BiP↓, 1,   XBP-1↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

LC3‑Ⅱ/LC3‑Ⅰ↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 2,   P53↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

P21↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

IGF-1↑, 1,   IGFBP1↑, 1,   TumCP↓, 2,  

Migration(tgid=13) ⓘ

Ca+2↑, 1,   Cartilage↑, 2,   MMP9↓, 1,   TGF-β↑, 2,   TumCI↓, 1,   TumCMig↓, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

NO↑, 1,   VEGF↑, 1,  

Barriers & Transport(tgid=15) ⓘ

IBI↑, 1,   MMP↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD25+↑, 1,   CD4+↑, 2,   COX2/PTGS2↓, 1,   FOXP3↑, 1,   GM-CSF↑, 1,   HMGB1↓, 1,   IFN-γ↓, 2,   IL10↑, 2,   IL1β↓, 3,   IL4↓, 2,   IL4↑, 1,   IL6↓, 6,   Imm↑, 3,   Inflam↓, 15,   IP-10/CXCL-10↑, 1,   LPS↓, 1,   M2 MC↑, 1,   MCP1/CCL2↓, 1,   NF-kB↓, 2,   NLRP3↓, 2,   PGE2↓, 1,   PGE2↑, 1,   TNF-α↓, 7,   Treg lymp↝, 1,   TREM-1↓, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↓, 1,   5HT↑, 1,   BDNF↑, 2,   EndoR↑, 1,   monoA↑, 1,   β-Endo↑, 1,  

Protein Aggregation(tgid=19) ⓘ

APP↓, 1,   Aβ↓, 1,   BACE/β-secretase↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

testos↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↝, 1,   Dose?, 1,   Dose↓, 1,   Dose↑, 2,   Dose↝, 26,   eff↑, 3,   eff↝, 1,   Synergy↑, 3,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 1,   AST↓, 1,   BG↓, 1,   BloodF↑, 1,   BMD↑, 3,   BP↓, 2,   creat↓, 1,   CRP↓, 2,   Hcy/homoC↝, 1,   IL6↓, 6,   PV↓, 1,   SpO2↑, 1,   TC↓, 1,   TG/TAG↓, 1,   UFR↑, 2,   UR↓, 1,   Urea↓, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiAge↑, 2,   antiAll↑, 3,   AntiCan↑, 1,   AntiDiabetic↑, 2,   antiPs↑, 1,   AntiTum↑, 1,   cachexia↓, 1,   cardioP↑, 4,   cognitive↑, 7,   cognitive∅, 1,   hepatoP↑, 4,   IPSS↓, 1,   memory↑, 5,   Mood↑, 5,   motorD↑, 2,   neuroP↑, 6,   Obesity↓, 2,   OS↑, 4,   Pain↓, 7,   QoL?, 1,   QoL↓, 1,   QoL↑, 28,   QoL∅, 1,   radioP↑, 1,   RenoP↑, 3,   Sleep↑, 1,   Strength↑, 1,   Stress↓, 1,   Stroke↓, 1,   Tinn↓, 1,   toxicity↓, 6,   toxicity∅, 3,   Weight↓, 1,   Weight↑, 1,   Wound Healing↑, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 1,   AntiViral↑, 1,   GutMicro↑, 1,   Sepsis↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↝, 2,  
Total Targets: 183

Scientific Paper Hit Count for: QoL, Quality of Life
8 Magnetic Fields
7 phytic acid, Inositol hexakisphosphate
6 Hydrogen Gas
5 Astragalus
5 Chemotherapy
4 Inositol
3 Acetyl-l-carnitine
3 diet FMD Fasting Mimicking Diet
3 Exercise
3 Fucoidan
3 Vitamin C (Ascorbic Acid)
3 Radiotherapy/Radiation
3 Melatonin
3 Mistletoe/Viscum album Extracts
2 3-bromopyruvate
2 beta-glucans
2 Brucea javanica
2 cetuximab
2 Chyawanprash
2 Selenium
2 CUSP9
2 Dichloroacetate
2 diet Short Term Fasting
2 Dandelion Root
2 Ellagic acid
2 eicosapentaenoic acid
2 Folic Acid, Vit B9
2 Lutein
2 MCT, metronomic chemo
2 Magnetic Field Rotating
2 Psilocybin
2 Selenite (Sodium)
1 Aromatherapy
1 Ashwagandha(Withaferin A)
1 immunotherapy
1 Bevacizumab (brand Avastin)
1 Bufalin/Huachansu
1 brusatol
1 Cat’s Claw
1 Camu camu
1 Choline
1 Coenzyme Q10
1 Curcumin
1 Oxygen, Hyperbaric
1 Chlorella (Chlorella vulgaris)
1 Docosahexaenoic Acid
1 Diindolylmethane
1 Ginkgo biloba-EGb 761
1 Flaxseed/Linseed
1 SDG/lignans
1 Flaxseed Oil
1 Vitamin D3
1 Ginger/6-Shogaol/Gingerol
1 High-Ozonide Oil
1 Hyperthermia
1 itraconazole
1 low dose naltrexone
1 Zeaxanthin
1 Lycopene
1 Matrine
1 Cisplatin
1 mebendazole
1 Modified Citrus Pectin
1 Lemon Balm/Melissa officinalis
1 Methylsulfonylmethane
1 Helleborus niger extracts – Christmas Rose
1 Mushroom Reishi
1 Oleocanthal
1 Paclitaxel/Taxol
1 Aidi injection
1 Patchouli Oil (Pogostemon cablin)
1 Phenethyl isothiocyanate
1 EMF
1 Shikonin
1 Spirulina(Arthrospira/Limnospira)
1 Vitamin B12
1 Whole Body Vibration
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:1141  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page